	Metastatic melanoma with heterologous bone after neoadjuvant immunotherapy: diagnostic insights. Pathologica Pepe L, Fiorentino V, Ieni A, Santarpia M, Fazio A, Vaccaro M, Borgia F, Ferrara G, Lentini M. PMID: 42157743 [PubMed - indexed for MEDLINE]
	Immune checkpoint inhibitor-associated lymphocytic colitis in a patient with metastatic melanoma. BMJ Case Rep Matar R, Abu Zeinah K, Modi T, Ducharme-Smith A. PMID: 42156103 [PubMed - indexed for MEDLINE]
	Survival and Pathological Outcomes of Neoadjuvant Chemoimmunotherapy Followed by Surgery in Locally Advanced Oral Squamous Cell Carcinoma. Cancer Control Wang Z, Li Y, Feng J, Wu L, Li T, Zhu X, Liang L. PMID: 42153903 [PubMed - indexed for MEDLINE]
	MAPK Inhibitor-Tolerant Persister Cells in Melanoma: Mechanisms and Therapeutic Vulnerabilities. Cancer Sci Shah B, Mayhew MM, Sellers J, Witt RG. PMID: 42153615 [PubMed - as supplied by publisher]
	Is there a role for adjuvant radiotherapy after partial laryngectomy? A propensity score matched analysis. Acta Otorhinolaryngol Ital Belgioia L, D'Onofrio I, Filauro M, Iandelli A, Marchi F, Mora F, Bacigalupo A, Boni L, Carmisciano L, Di Pressa F, Tosoni A, Della Peruta V, Fermi M, Mattioli F, Guida C, Tortoriello G, Presutti L, Peretti G, D'Angelo E. PMID: 42153417 [PubMed - indexed for MEDLINE]
	The neck matters: optimising lymph node management in laryngeal cancer. Acta Otorhinolaryngol Ital Guarino P, Chiari F, Petruzzi G, Mazzola F, Fior M, Borrelli A, Pellini R, Spriano G, Ricciardiello F, Caporale CD. PMID: 42153416 [PubMed - indexed for MEDLINE]
	Five-year outcomes of transoral robotic surgery with or without neoadjuvant chemotherapy in laryngeal squamous cell carcinoma: a preliminary experience. Acta Otorhinolaryngol Ital De Virgilio A, Meliante PG, D'Avino L, Kim SH. PMID: 42153415 [PubMed - indexed for MEDLINE]
	A systematic review of surgical outcomes and postoperative complications based on free flap selection for reconstructing primary or recurrent locally advanced laryngeal-hypopharyngeal tumours. Acta Otorhinolaryngol Ital De Luca P, Di Stadio A, Abousiam M, de Campora L, Simone M, Pangallo S, Radici M, Calabrese L, Benazzo M, Camaioni A, Gazzini L. PMID: 42153413 [PubMed - indexed for MEDLINE]
	Margin burden and postoperative management after transoral laser microsurgery for laryngeal glottic squamous cell carcinoma: a multicentre retrospective study on 1216 patients. Acta Otorhinolaryngol Ital Chu F, Marchi F, Sampieri C, Zorzi SF, Tagliabue M, Bellini E, Filauro M, Moro C, Ajasllari G, Xavier-Aviles-Jurado F, Delia Ramírez-Ruiz R, Costa JM, Gros JL, Motta G, Della Peruta V, Tortoriello G, Vilaseca I, Peretti G, Ansarin M. PMID: 42153411 [PubMed - indexed for MEDLINE]
	Evolution of Thiosemicarbazones: From First- to Second-Generation Metal Chelators and Their Reactive Oxygen Species-Mediated Effects in Melanoma. ChemistryOpen Alim R, Andrew SD, Parkinson CJ. PMID: 42152802 [PubMed - indexed for MEDLINE]
	Exploring the paradoxical association of sun exposure and melanoma-specific mortality: The Norwegian Women and Health (NOWAC) Study. Eur J Cancer Perrier F, Ahimbisibwe A, Valberg M, Green AC, Ghiasvand R, Rueegg CS, Weiderpass E, Braaten TB, Robsahm TE, Veierød MB. PMID: 42150442 [PubMed - as supplied by publisher]
	Method to Study Skin Cancer: Two-Stage Chemically Induced Carcinogenesis in Mouse Skin. Methods Mol Biol Mardaryev AN, Fatima I, Sharov AA. PMID: 42149461 [PubMed - indexed for MEDLINE]
	Phytosomes against melanoma: disrupting molecular pathways with targeted phytochemical delivery. Discov Nano Uniyal P, Bhardwaj N, Raina D. PMID: 42149379 [PubMed]
	Phenotypic and Functional Characteristics of CD8+ T cells Predict Clinical Outcome Following TIL Therapy in a Randomized Phase III Trial in Advanced Melanoma. Clin Cancer Res Granhøj JS, Mannering SMH, Madsen K, W Hendel H, Draghi A, Jedema I, Lievense J, Nijenhuis C, Nuijen B, V Zon M, W Rohaan M, Tak WS, Klobuch S, Borch TH, Met Ö, Haanen J, Donia M, Svane IM. PMID: 42149143 [PubMed - as supplied by publisher]
	Case Report: Long-term survival in advanced PD-L1-high squamous cell lung cancer following severe immune-related cardiotoxicity. Front Immunol Zhang QQ, Luo XX, Chen H, Wang W, Liu J, Li Y, Qiao HL, Chen L, Feng ZQ. PMID: 42148146 [PubMed - indexed for MEDLINE]
	The immune microenvironment of HPV-associated cancers: from viral oncogenesis to immunotherapy response. Front Immunol Pla, Fialová A. PMID: 42148142 [PubMed - indexed for MEDLINE]
	Case Report: Anti-PD-1 therapy as a catalyst for the rapid transformation of a hepatic nodule into HCC: a "soil and seed" paradox in metachronous triple primary malignancies? Front Immunol Yang X, Kong D, Lai B, Zhang C, Li N. PMID: 42148120 [PubMed - indexed for MEDLINE]
	Genomic alterations and dynamic molecular residual disease monitoring predict pathological response to neoadjuvant chemoimmunotherapy in esophageal squamous cell carcinoma. Front Immunol Shen D, Liang J, Yan J, Lu W, Chen D, Tao K, Wang M, Chen S, Chen Q. PMID: 42148099 [PubMed - indexed for MEDLINE]
	Size and Macroscopic Type of Type B2 Vessel Areas in JES Classification for Predicting Invasion Depth: A Multicenter Prospective Study. Dig Endosc Yoshida M, Urabe Y, Kadota T, Nonaka S, Ohno K, Kitamura Y, Takahashi H, Yoshio T, Sasaki F, Ono Y, Igarashi K, Hirasawa D, Takeuchi M, Mori K, Ishihara R. PMID: 42144869 [PubMed - indexed for MEDLINE]
	Zerumbone Induced ROS-Mediated Autophagic Cell Death in Human Melanoma Cells: An InÂ Vitro and InÂ Vivo Study. Biofactors Chen SJ, Hseu YC, Zhang YM, Pandey S, Bhat AA, Li YH, Huang PJ, Yang HL, Hseu JH. PMID: 42144730 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 142819

Page 1 of 7141



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy